Merck & Co., Inc. is 51.1x more valuable than Mirum Pharmaceuticals, Inc. by market capitalization ($293.16 B vs $5.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MIRM | MRK |
|---|---|---|
| Market cap | $5.73 B | $293.16 B |
| US-listed rank | #1294 | #44 |
| Revenue (latest FY) | $521.31M | $65.01B |
| Net income (latest FY) | -$23.36M | $18.25B |
| Net margin | -4.5% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 612 | 996 |
Merck & Co., Inc. is 51.1x more valuable than Mirum Pharmaceuticals, Inc. by market capitalization ($293.16 B vs $5.73 B).
In their latest fiscal years, Mirum Pharmaceuticals, Inc. reported $521.31M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Mirum Pharmaceuticals, Inc. and Merck & Co., Inc., or browse the full rankings.